class action lawsuit

Paysafe Limited faces securities fraud lawsuit after missing Q3 revenue by $5.8M, reporting $87.7M loss. Stock plummeted 27.6% on undisclosed risks.

Class action lawsuit filed against Inovio Pharmaceuticals ($INO) for allegedly making false statements about INO-3107 treatment and manufacturing capabilities, causing significant stock declines.

NuScale Power faces securities fraud lawsuit after disclosing $495M payment to inexperienced nuclear startup ENTRA1 Energy, triggering 12.4% stock decline.

Class action lawsuit filed against $ALIT alleging executives made false statements about growth and cost cuts while concealing sales execution failures.

Class action lawsuit filed against $ALIT over alleged false statements on growth and cost-cutting. Stock fell 18.3% in August 2025, 38.2% in February 2026 following earnings misses.

Class action filed against Picard Medical ($PMI) for alleged securities fraud involving false promotions, insider share dumping, and omitted risk disclosures. Lead plaintiff deadline April 3, 2026.

Class action lawsuit filed against $UQRR alleging materially false statements about FDA approval and BLA timeline delays. Investors urged to join by April 13, 2026 deadline.

Class action lawsuit filed against REGENXBIO alleging false statements about RGX-111 gene therapy development and clinical trials, covering investors from February 2022 through January 2026.

Class action lawsuit filed against $PYPL alleging executives made false statements about revenue projections and 2027 targets under CEO James Chriss.

Class action filed against PomDoctor ($POM) alleging stock fraud through false statements, social media misinformation, and coordinated insider share dumping.

Law firm files class action against Kyndryl for alleged securities fraud, false financial statements, and internal control failures affecting investors from August 2024 through February 2026.

Masonite faces class action alleging it failed to disclose Owens Corning acquisition offers while repurchasing stock at depressed prices from June 2023 to February 2024.

Paysafe faces securities fraud lawsuit alleging undisclosed high-risk merchant exposure and understated credit reserves during nine-month period through November 2025.

Driven Brands stock plummets 40% after disclosing material accounting errors spanning fiscal 2023-2025, triggering class action lawsuit for investors purchasing between May 2023 and February 2026.

Portnoy Law Firm files class action against $AQST for allegedly misleading investors about Anaphylm FDA prospects. Stock plunged 37% after deficiency disclosure.

Portnoy Law Firm launches class action lawsuit against Alight, Inc. for allegedly making false revenue statements. Stock plummeted 56% cumulatively across two separate crashes in 2025-2026.

Portnoy Law Firm files class action against Camping World Holdings ($CWH) for allegedly making false statements about inventory management and consumer demand between April 2025 and February 2026.

Portnoy Law Firm launches class action against Apollo Global Management alleging undisclosed Epstein communications. Stock declined 5-6% following February 2026 media revelations.

Boston Scientific faces class action lawsuit after 17% stock decline following $0.45 EPS miss versus $0.48-$0.52 guidance, amid alleged undisclosed Electrophysiology market share losses.

Nektar Therapeutics faces class action lawsuit over alleged failure to disclose enrollment protocol violations in failed Phase 2b REZOLVE-AA trial, triggering 8% stock decline.